Commercialization: Page 61
-
PharmaVoice Team/PharmaVoice
Commercialization - Decisions, Decisions, Decisions
In recent years, the research and development landscape in the pharmaceutical industry has radically changed. The search for the next big blockbuster has been replaced by the search for medicines targeted toward specific patient subpopulations or toward diseases with high unmet medical need to ma...
By Dr. Michael Ackerman • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Pharmaceutical Call Centers Build relationships with Healthcare Providers and Patients
Pharmaceutical, biotechnology, and medical device companies have a significant need to build relationships with prescribers and patients. However, these audiences have very different needs that require companies to take varying approaches to communicate effectively with them. Healthcare providers...
By Lou Shapiro • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
The Emergence of Strategic Outsourcing in Clinical Supply Chain Management
Ten years ago few biopharmaceutical industry professionals could have predicted how broadly the landscape for outsourcing would change by 2012. Most companies were outsourcing in a tactical, project-by-project manner and utilizing dozens of providers across functional areas. Some were moving to a...
By Robert Dunlop • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Why Outsourcing Patient Enrollment to a Specialist Makes Sense
Richard Malcolm, Ph.D., CEO, Acurian Disruptive change is needed in clinical trial management, an industry where inadequate enrollment has become the biggest driver of wasted dollars. The cost of patient enrollment is now the single largest part of the total trial budget, representing 32% of the ...
By Richard Malcolm • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Help from The Outside
Help from the Outside Showcase Feature: Outsourcing Carolyn Gretton As life-sciences companies look to improve operational efficiencies within their organizations, they are increasingly reducing the number of activities that they would categorize as core competencies and outsourcing them to thir...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Trends, Challenges, and Best Practices of Global Product Launches
Companies both large and small are expanding their global launch approach. Robin Robinson With all the variances and complexities involved in launching a product globally, especially around regulatory and approval requirements within various regions across countries, one could argue that there is...
By Robin Robinson • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
C-Suite CROs
Insights from the C-Suite: Contract Research Organizations CRO growth continues to outpace other sectors. Frost &?Sullivan estimates that the CRO market earned revenue of $11.43 billion in 2010 and estimates that the sector will top $20.09 billion in 2017. According to a recent Frost & Su...
By Taren Grom • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Digital Patient-Centric Communications: Listen and Learn
Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the ...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Life-Sciences Companies Face Increased Complexity in Aggregate Spend Tracking and Reporting Trend: Aggregate spend mandates within the life-sciences industry are continuing to evolve in 2012 amid ongoing cha...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Social Media
Social Media trends, regs, and apps By Robin Robinson Palio Launches Wiki for Healthcare and Pharmaceutical Apps Trend Watch: Use of wikis to monitor social media activity spreads to apps. Our PharmApps wiki gives users the ability to comment, write a review, rate apps, share, and upload new app...
By Robin Robinson • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn Gretton New Tool from HRM Aims to Improve Medication Adherence, Patient Outcomes Trend: A growing number of healthcare providers are using intuitive technological tools to connect directly with patients to provide info...
By Carolyn Gretton • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Milestones… Spectrum Celebrates 15 Years Spectrum, a health and science communications agency, is celebrating its 15th anniversary. The independent agency, which was founded by John Seng in 1996, is committed to achieving the goals of clients who are involved with issues, pro...
By Taren Grom • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
New commercial models paying dividends… Creating value — the goal for all companies — and how they achieve this goal are as different as the companies themselves. According to a recent report — Strength in the Storm: How Biopharmaceutical and Medical Technology Companies Can Create Value in a Cha...
By Taren Grom • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
Healthcare Decisions in the Age of Social Networks: The Facts About Influencers, Trust and Privacy
Clearly, social networks are an integral part of our lives today. But how much do they impact healthcare decisions? Do people trust — and act on — what they read online? To find out, SSI conducted a study with more than 1,450 U.S. consumers 13 and older. About half of our respondents are from our...
By Chris Deangelis • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Search and Social Media for the Pharmaceutical Industry
Much has been said about the role of social media as a marketing vehicle. It offers customers and audiences a way to interact with brands like never before. The paradigm of audience has shifted as our “push" messaging has evolved to a conversation. In the pharmaceutical industry, we are looking t...
By Christopher Cullman • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Nearly All U.S. Doctors are Now on Social Media; Shouldn't You be Too?
Pharma may be a late adopter of social media, but doctors are all in. According to a recent American Medical News article, Frost & Sullivan found that 84% of doctors use social media for personal purposes. This was confirmed by a QuantiaMD study in which nearly 90% of physicians reported they...
By Terry Nugent • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Healthcare And Social Media: A Winning Formula
Healthcare and Social Media: A Winning Formula Do you know what physicians are saying to each other about your company and its products? Could you identify the top three fears of patients suffering from a chronic condition treated by your market leading therapy? Social media sites can get pharmac...
By Chinmay Bhatt • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Six Social Shifts: Trends Affecting Pharma Now
Like all things digital, the social media environment is moving so fast that even news from just three months ago seems old. The regulatory environment of pharma exacerbates the challenge to stay ahead of this social world. The pharma industry was anything but an early adopter in the social space...
By Whitney Poma • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Engaging Healthcare Professionals with Social Media
Social media and technology have turned healthcare consumers into e-patients. The “e" is no longer for electronic, but rather for evolved, empowered, and engaged. E-patients are evolved to the point of being screen agnostic when it comes to digital media consumption. They are empowered to make ch...
By Erin Byrne • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Insights from the C-Suite: Specialty Pharma
The growing U.S. specialty pharmaceutical market comprises more than 90 companies marketing more than 550 prescription pharmaceutical products and is valued at about $21 billion, according to MCD Group. According to MCD Group, specialty pharmaceuticals are mainly prescribed by clinical specialist...
By Taren Grom • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Pharma 3.0 Next Steps
Robin Robinson Pharma Expands Disease Categories of 3.0 Efforts Between 2006 and 2009, 24% of Pharma 3.0 initiatives focused first on diabetes and metabolics. In 2010, oncology moved to the top with 15% of the year’s initiatives, and diabetes and metabolics tied for second with immunoscience/...
By PharmaVoice Team • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Alex AZAR Maria CROWE Dave RICKS Lilly Makes Management Changes Lilly has announced a number of key management appointments. Alex Azar has been promoted to president of Lilly USA, the company’s...
By Carolyn Gretton • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn Gretton ImpactRx Adds Tablet Detailing to Analytics Offerings Trend: Growing physician adoption of tablet computers is prompting pharma brand teams to design and execute messaging strategies that more effectively employ...
By Carolyn Gretton • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Social Media
Social Media trends, regs, and apps By Robin Robinson Google+ Or Minus For Pharma? Trend Watch: Will The Industry Use Google+ Business Pages? No Need to Rush, Experts Say In June 2011, Google launched Google+ for personal use, and many in the social media industry debated whether a G+ for busines...
By Taren Grom • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
In Memoriam… Robert L. (Bob) Gerbig, co-founder and former CEO of Gerbig, Snell/Weisheimer & Associates (GSW, now part of inVentiv), has died at 66. Mr. Gerbig began his career in pharmaceuticals in 1969 with Marion Merrell-Dow, where he held various positions in sales, marketing, and merchan...
By Taren Grom • Dec. 22, 2011
Previous
